DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing
Article in International Immunopharmacology (June 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer
Article in Frontiers in Immunology (January 2024)
Single‐cell sequencing of head and neck carcinoma: Transcriptional landscape and prognostic model based on malignant epithelial cell features
Article in The FASEB Journal (December 2023)